Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis
CONCLUSION: This meta-analysis showed a potential association between PPI use and composite poor outcome, but not susceptibility.PROSPERO ID: CRD42020224286.PMID:33840053 | DOI:10.1007/s43440-021-00263-x
Source: Pharmacological Reports - Category: Drugs & Pharmacology Authors: Raymond Pranata Ian Huang Sherly Lawrensia Joshua Henrina Michael Anthonius Lim Antonia Anna Lukito Raden Ayu Tuty Kuswardhani I Dewa Nyoman Wibawa Source Type: research
More News: Chronic Kidney Disease | COVID-19 | Databases & Libraries | Diabetes | Drugs & Pharmacology | Endocrinology | Hypertension | Legislation | Pneumonia | Proton Pump Inhibitors PPIs | Study | Urology & Nephrology